Multi-view multi-level contrastive graph convolutional network for cancer subtyping on multi-omics data.

Journal: Briefings in bioinformatics
PMID:

Abstract

Cancer is a highly diverse group of diseases, and each type of cancer can be further divided into various subtypes according to specific characteristics, cellular origins, and molecular markers. Subtyping helps in tailoring treatment and prognosis accuracy. However, the existing studies are more concerned with integrating different omics data to discover potential connections, but ignoring the relationships between consensus information and individual information within each omics level during the integration process. To this end, we propose a novel fusion-free method called multi-view multi-level contrastive graph convolutional network (M$^{2}$CGCN) for cancer subtyping. M$^{2}$CGCN learns multi-level features, i.e. high-level and low-level features, respectively. The low-level features from each view capture the intrinsic information in each omics by reconstruction of node attribute and graph structures. The high-level features achieve cancer subtyping via contrastive learning. Comprehensive experiments were performed on 34 multi-omics cancer datasets. The findings indicate that M$^{2}$CGCN achieves results comparable to or surpassing many state-of-the-art methods.

Authors

  • Bo Yang
    Center for Cognition and Brain Disorders, Hangzhou Normal University, Hangzhou, Zhejiang Province 311121, China.
  • Chenxi Cui
    School of Computer Science & The Shaanxi Key Laboratory of Clothing Intelligence, Xi'an Polytechnic University, Xi'an 710048, China.
  • Meng Wang
    State Key Laboratory of Urban Water Resource and Environment, School of Environment, Harbin Institute of Technology, Harbin 150001, China.
  • Hong Ji
  • Feiyue Gao
    School of Computer Science & The Shaanxi Key Laboratory of Clothing Intelligence, Xi'an Polytechnic University, Xi'an 710048, China.